Glatiramer acetate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 14:50, September 9, 2019 by Notjusttired (talk | contribs) (→‎ME/CFS: bid start time)

Copaxone or glatopa, and glatiramer, its generic form, is a drug licensed to reduce relapses in patients with multiple sclerosis.[1]

ME/CFS[edit | edit source]

Dr. Ron Davis on Copaxone in ME/CFS. Inaugural Harvard Symposium, Sep 2019.

Ron Davis of the Open Medicine Foundation reports that when the nanoneedle electrical impedance test on ME/CFS cells was used, Copaxone made the cells respond in the same way as healthy cells did, suggesting it is a potential treatment for ME/CFS.[2]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Copaxone: Uses, Dosage, Side Effects". Drugs.com. Retrieved April 30, 2019.
  2. Davis, Ron (September 2019). "Dr. Ron Davis Presents on ME/CFS Research Activities at Stanford at Inaugural Harvard Symposium". Retrieved September 8, 2019. Cite has empty unknown parameter: |dead-url= (help)